Affiliation:
1. Department of Obstetrics and Gynecology, School of Medicine Hyogo Medical University Nishinomiya Hyogo Japan
2. Department of Surgical Pathology, School of Medicine Hyogo Medical University Nishinomiya Hyogo Japan
Abstract
AbstractMultimodal treatment, including assisted reproductive technology, is necessary in young patients with advanced borderline ovarian tumors. However, the details of long‐term follow‐up cases have not been reported. In this report, a 19‐year‐old patient presented with a stage IIIC serous borderline tumor. The patient underwent five fertility‐sparing surgeries. The tumor did not respond to any of the three lines of chemotherapy administered. Serological and radiological responses were observed following hormonal treatment with leuprorelin, followed by a fourth surgery. Before the planned fifth surgery for complete resection of both adnexa, cryopreservation of the fertilized eggs was performed. At age 36, when the disease‐free interval exceeded the previous one, we proposed embryo transfer; however, she declined fertility treatment. The patient had developed rheumatoid arthritis and childbirth not a priority. The patient had lived without any evidence of disease for 7 years following the last surgery and 20 years after the initial visit.
Subject
Obstetrics and Gynecology
Reference14 articles.
1. Borderline epithelial tumors of the ovary
2. Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: A Kansai Clinical Oncology Group study (KCOG9812)
3. A phase I/II study of docetaxel and gemcitabine combination for chemotherapy‐resistant ovarian cancer;Itani Y;Anticancer Res,2009
4. Phase II study of carboplatin and weekly irinotecan combination chemotherapy in recurrent ovarian cancer: a Kansai clinical oncology group study (KCOG0330);Tsubamoto H;Anticancer Res,2013
5. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献